PL2136792T3 - Mikropeletki wytwarzane w procesie ze stapianiem - Google Patents

Mikropeletki wytwarzane w procesie ze stapianiem

Info

Publication number
PL2136792T3
PL2136792T3 PL08717955T PL08717955T PL2136792T3 PL 2136792 T3 PL2136792 T3 PL 2136792T3 PL 08717955 T PL08717955 T PL 08717955T PL 08717955 T PL08717955 T PL 08717955T PL 2136792 T3 PL2136792 T3 PL 2136792T3
Authority
PL
Poland
Prior art keywords
melt process
micropellets
micropellets made
melt
Prior art date
Application number
PL08717955T
Other languages
English (en)
Inventor
Rok Dreu
Miha Homar
Mateja Burjak
Janez Kerc
Stanko Srcic
Original Assignee
Lek Pharmaceuticals
Rok Dreu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38241063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2136792(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lek Pharmaceuticals, Rok Dreu filed Critical Lek Pharmaceuticals
Publication of PL2136792T3 publication Critical patent/PL2136792T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08717955T 2007-03-19 2008-03-18 Mikropeletki wytwarzane w procesie ze stapianiem PL2136792T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07104410A EP1972336A1 (en) 2007-03-19 2007-03-19 Hot-melt micropellets
EP08717955A EP2136792B1 (en) 2007-03-19 2008-03-18 Hot-melt micropellets
PCT/EP2008/053223 WO2008113803A1 (en) 2007-03-19 2008-03-18 Hot-melt micropellets

Publications (1)

Publication Number Publication Date
PL2136792T3 true PL2136792T3 (pl) 2013-09-30

Family

ID=38241063

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08717955T PL2136792T3 (pl) 2007-03-19 2008-03-18 Mikropeletki wytwarzane w procesie ze stapianiem

Country Status (5)

Country Link
US (1) US20100172969A1 (pl)
EP (2) EP1972336A1 (pl)
PL (1) PL2136792T3 (pl)
SI (1) SI2136792T1 (pl)
WO (1) WO2008113803A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1006780B (el) * 2009-04-10 2010-05-20 Specifar Abee ���������� ������� ��� ������������� ��������� Διεργασια παραγωγης ταχεως αποσαθρουμενων σφαιριδιων, κοκκιων και/'η μιγματων τους
US9510617B2 (en) 2012-04-13 2016-12-06 Frito-Lay North America, Inc. Micropellets of fine particle nutrients and methods of incorporating same into snack food products
US9271523B2 (en) 2012-05-23 2016-03-01 Dennis Williams Rotor assembly with one-piece finger member
EP2897647A1 (en) * 2012-09-18 2015-07-29 McNeil-PPC, Inc. Suspension pharmaceutical formulations comprising low melting propionic acid derivative particles
CA2884270A1 (en) * 2012-09-18 2014-03-27 Mcneil-Ppc, Inc. Sustained release oral dosage forms comprising low melting propionic acid derivative particles
WO2014207769A1 (en) 2013-06-27 2014-12-31 Mylan Laboratories Ltd Process for the preparation of nepafenac
US9669574B2 (en) 2014-11-11 2017-06-06 Frito-Lay North America, Inc. Twin screw rotary head extruder, method of extrusion and random extruded products
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CN105343033B (zh) * 2015-12-14 2018-03-20 西南药业股份有限公司 一种布洛芬缓释微丸及其制备方法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
FR3113238B1 (fr) 2020-08-05 2024-04-05 Gattefosse Sas Utilisation comme excipient, d’un melange de macrogolglyceride laurique et de polyethylene glycol

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI894611L (fi) * 1988-09-30 1990-03-31 May & Baker Ltd Granulaera farmaceutiska preparat.
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
DE4118433C2 (de) * 1991-06-05 1994-12-01 Herbert Huettlin Fließbettapparatur zum Behandeln partikelförmigen Gutes
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE69811233T2 (de) * 1997-10-27 2003-11-20 Merck Patent Gmbh Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
FR2811912B1 (fr) * 2000-07-21 2003-02-07 Gattefosse Ets Sa Procede d'enrobage de particules solides par un agent thermofusible, et particules solides ainsi enrobees
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
TW200533374A (en) * 2003-11-13 2005-10-16 Alza Corp Melt blend dispersions
WO2005079752A2 (en) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
JP2008539240A (ja) * 2005-04-25 2008-11-13 テバ ファーマシュ−ティカルズ ユーエスエー， インコーポレイテッド 持続放出性処方物

Also Published As

Publication number Publication date
EP2136792B1 (en) 2012-12-26
WO2008113803A1 (en) 2008-09-25
SI2136792T1 (sl) 2013-11-29
EP1972336A1 (en) 2008-09-24
US20100172969A1 (en) 2010-07-08
EP2136792A1 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
PL2136792T3 (pl) Mikropeletki wytwarzane w procesie ze stapianiem
DK2212453T3 (da) Fremgangsmåde til at danne en bioaktiv belægning
BRPI0812304A2 (pt) Processo para a produção de p4o6
EP2149441A4 (en) VACUUM-ASSISTED RTM METHOD
BRPI0812422A2 (pt) Processo de preparação de um aldeído hidroxiaromático
FI20075465A0 (fi) Talteenottomenetelmä
DK2102117T3 (da) Fremgangsmdåe til fremstilling af en mineralsmelte
BRPI0811644A2 (pt) Processo para a produção de pirazóis
DK1961770T3 (da) Fremgangsmåde til fremstilling af et kompleks
DK2074034T3 (da) Fremgangsmåde til fremstilling af flervæggede beholdere
BRPI0806679A2 (pt) Processo aperfeiçoado de produção de alquilaromático
DK2036818T3 (da) Fremgangsmåde til fremstilling af en palleløs emballageenhed
DE602007004441D1 (de) Reifenwechselgerät
EP2371509A4 (en) FORMING METHOD
BRPI0816237A2 (pt) Processo de ciclopropanação
BRPI0811510A2 (pt) Método para a produção de moldes
EP2169142A4 (en) METHOD FOR MANUFACTURING FLOOR
EP2089208A4 (en) MACHINE FOR CONTINUOUS SHAPING
BRPI0813861A2 (pt) processos de produção de estireno
EP2313241A4 (en) FORM WITH SHAPE TOOL
ES1065713Y (es) Maquina quitamanchas
FR2921080B1 (fr) Machine de blachisserie
FI20085807L (fi) Menetelmä essitalopraamin valmistamiseksi
BRPI0815419A2 (pt) Método de produção
FI20070554A0 (fi) Uusi valmistusmenetelmä